BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu Y, Shui X, Liang Z, Huang Z, Qi Y, He Y, Chen C, Luo H, Lei W. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review). Int J Mol Med 2020;46:936-48. [PMID: 32705240 DOI: 10.3892/ijmm.2020.4674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Dong Y, Liu J, Qian L, Wang T, Gao X, Wang K, Zhou L. Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases. Oxid Med Cell Longev 2020;2020:5860356. [PMID: 33282111 DOI: 10.1155/2020/5860356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 de Oliveira RCG, Gardev E, Shaddox LM. Dysbiotic relationship between arthritis and the oral-gut microbiome. A critical review. J Periodontal Res 2022. [PMID: 35583216 DOI: 10.1111/jre.13002] [Reference Citation Analysis]
3 Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives. Aging Dis 2022;13:1106-26. [PMID: 35855347 DOI: 10.14336/AD.2022.0104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ji X, Chang K, Chen M, Zhu L, Osman A, Yin H, Zhao L. In vitro fermentation of chitooligosaccharides and their effects on human fecal microbial community structure and metabolites. LWT 2021;144:111224. [DOI: 10.1016/j.lwt.2021.111224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Yang H, Pan R, Wang J, Zheng L, Li Z, Guo Q, Wang C. Modulation of the Gut Microbiota and Liver Transcriptome by Red Yeast Rice and Monascus Pigment Fermented by Purple Monascus SHM1105 in Rats Fed with a High-Fat Diet. Front Pharmacol 2020;11:599760. [PMID: 33551805 DOI: 10.3389/fphar.2020.599760] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, Dobrev D, Linz D. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res 2021:cvab292. [PMID: 34550344 DOI: 10.1093/cvr/cvab292] [Reference Citation Analysis]
7 Liu L, Su J, Li R, Luo F. Changes in Intestinal Flora Structure and Metabolites Are Associated With Myocardial Fibrosis in Patients With Persistent Atrial Fibrillation. Front Nutr 2021;8:702085. [PMID: 34497820 DOI: 10.3389/fnut.2021.702085] [Reference Citation Analysis]
8 Feng W, Liu J, Cheng H, Zhang D, Tan Y, Peng C. Dietary compounds in modulation of gut microbiota-derived metabolites. Front Nutr 2022;9:939571. [DOI: 10.3389/fnut.2022.939571] [Reference Citation Analysis]
9 Chen J, Hall S, Vitetta L. Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Rev Med Virol 2021;31:1-13. [PMID: 34546607 DOI: 10.1002/rmv.2211] [Cited by in Crossref: 8] [Article Influence: 8.0] [Reference Citation Analysis]